89Zr-Bevacizumab PET Imaging in Patients With Renal Cell Carcinoma Treated With Sunitinib or Bevacizumab Plus Interferon; a Pilot Study.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Bevacizumab (Primary) ; Interferon; Sunitinib
- Indications Renal cancer
- Focus Biomarker; Therapeutic Use
- Acronyms Renimage
- 27 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 27 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2009 New trial record